Thetis Pharmaceuticals is a biopharmaceutical company developing immuno-resolving oral therapies for the treatment of IBD. The Thetis approach is based on leveraging the robust pharmacology of bioactive lipids with its proprietary technology platform to overcome the stability, manufacturing, formulation and patentability hurdles that have limited their development as pharmaceutical agents.